Page last updated: 2024-10-21

acebutolol and Acute Brain Injuries

acebutolol has been researched along with Acute Brain Injuries in 1 studies

Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Basagni, B1
Navarrete, E1
Bertoni, D1
Cattran, C1
Mapelli, D1
Oddy, M1
De Tanti, A1

Other Studies

1 other study available for acebutolol and Acute Brain Injuries

ArticleYear
The Italian version of the Brain Injury Rehabilitation Trust (BIRT) personality questionnaires: five new measures of personality change after acquired brain injury.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2015, Volume: 36, Issue:10

    Topics: Acebutolol; Adult; Brain Injuries; Female; Humans; Language; Male; Middle Aged; Personality Tests; T

2015